title: [A phase II clinical trial of human urinary CSF (P-100) in pediatric patients].
authors: M
authors: M
authors: Tsuchida
authors: A
authors: A
authors: Ohara
authors: I
authors: I
authors: Tsukimoto
authors: Y
authors: Y
authors: Hanawa
authors: J
authors: J
authors: Akatsuka
authors: Y
authors: Y
authors: Hoshi
authors: Y
authors: Y
authors: Ueda
authors: M
authors: M
authors: Yamamoto
authors: T
authors: T
authors: Akabane
authors: J
authors: J
authors: Komiyama
mesh_terms: D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor; D006098:Granulocytes / Q000473:pathology; D006801:Humans; D007223:Infant; D007564:Japan; D008297:Male; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D016179:Granulocyte Colony-Stimulating Factor